Tetrahydrocurcumin (THC) also referred to as "white curcumin", is a stable colourless hydrogenated product of curcumin with superior antioxidant and anti-inflammatory properties.
Introduction
Curcumin, a yellow coloured polyphenolic compound derived from the rhizome of the herb Curcuma longa L, has been characterized as an excellent molecule among many naturally occurring compounds, for treatment of several skin inflammatory conditions like atopic dermatitis [1] [2] [3] . It alleviates the skin conditions by mode of antioxidant and anti-inflammatory actions in addition to wound repairing capabilities [4] [5] [6] . However, inspite of its proven efficacy and safety, it has not yet been approved as a therapeutic agent and till date no commercialisation is in pipeline.
Major limitations to the latter are its low bioavailability assigned to it poor aqueous solubility (11 ng/mL) especially at acidic and physiological pH, higher log P value of 3.29, and instability at physiological pH (7.4) and in the presence of light 7 . In this regard, several nanotechnology based drug delivery systems are being developed. These include polymeric nanoparticles 8 , solid lipid nanoparticles [9] [10] [11] , liposomes 12 , and microemulsions 13, 14 . However, a major problem associated with the topical application of curcumin is the yellow stain left on the skin post application.
Tetrahydrocurcumin (THC), a metabolite of curcumin is prophesied beneficial for local treatments in the gut [15] [16] [17] . It is an excellent antioxidant molecule which possesses superior stability at physiological pH (7.4) 18 and in plasma, in addition to being colourless. Moreover, THC is reported to possess an anti-inflammatory activity better than curcumin 18 . THC is however an underexplored molecule for its application in topical disorders though a few reports do indicate its use in cosmetic preparations as a depigmenting agent 19 . Due to its poor aqueous solubility (0.0056 mg/mL) and a log P value of 2.98, THC could be expected to be a poor skin permeant 20, 21 .
Nano-couturing of phytochemicals, has been evidenced to result in bioavailable formulations as a result of improved solubility and stability. Conventional topical treatment using ointments or creams requires frequent application and has shown variable patient responses which results in reduced patient compliance. Nanoparticles based drug delivery systems (e.g., liposomes, nano and microemulsions and lipid nanoparticles) have received particular attention for their ability to improve penetration across stratum corneum and for their specific targeting properties 22 .
Drug loaded lipid based nanoparticles in form of a dispersion or post incorporation into a hydrogel, ointment or a cream base have shown advantages like increased bioavailability, physical stability, protection of incorporated thermolabile drugs from degradation and controlled release [23] [24] [25] .
Present study is an attempt to improve the topical bioavailability of THC, post incorporation into a nano-carrier system(s) with its final dosage as a hydrogel. SLNs, were prepared using a spontaneous, feasible and lab scalable microemulsification technique. THC-SLNs dispersion was evaluated for particle size, polydispersity index (PI), zeta potential, total drug content, entrapment efficiency and TEM. DSC and X-ray diffraction studies were performed to confirm the formation of THC-SLNs. In vitro drug release via SLNs was carried out using dialysis membrane. Further, THC-SLNs hydrogel was evaluated for pH, rheological characteristics, and occlusivity measurements were also carried out. These were followed by skin irritancy (OECD 404) and exvivo permeation studies in animals. Stability studies were performed on the THC-SLNs and its hydrogel in accordance to ICH guidelines Q1A (R2). Finally, the proof of concept studies in an excision wound mice model of inflammation was performed. As inflammation is innate to most of the skin disorders, it was proposed to evaluate its efficacy in an excision wound mice model, wherein the role of oxidative stress in addition to inflammation has been indicated. Post topical application, efficacy of THC-SLNs gel in terms of antioxidant balance and anti-inflammatory activity was determined. Though ample research on nanotechnological intervention on curcumin has been reported and published by us and other scientists working in this area, however, white curcumin has remained as an unexplored molecule. To the best of our knowledge this is the first paper elaborating the therapeutic usefulness of white curcumin for skin inflammation with superior properties of providing a cosmetic elegance to the product owing to its colorless and non-staining nature in addition to being a better anti-oxidant and an anti-inflammatory agent.
Material and methods

Materials
Tetrahydrocurcumin was a generous gift sample from Sanat Pharmaceuticals Ltd. (New Delhi, India Chloroform and diethyl ether were purchased from Sisco Research Laboratories (Mumbai, India).
Ethylene diamine tetra acetic acid and triethanolamine were supplied by SD Fine Chemicals (Mumbai, India). Formalin and hydrochloric acid were obtained by Qualigens Fine Chemicals (Mumbai, India). Ellman reagent was purchased from Himedia Laboratories Ltd. (Mumbai, India).
Methanol and polyethylene glycol were obtained from Fisher Scientific (Mumbai, India). Ethanol was obtained from Changshu Yanguan Chemicals (China). Phospholipon G was procured as a gift sample from Gattefosse SAS, France.
Preparation of THC-SLNs
THC loaded SLNs were prepared by microemulsification method 26 . Briefly, tween 80 (30%), phosphatydylcholine (PC) (2%) and water were placed together in a beaker and heated to the lipid melting temperature. Compritol ® 888 ATO (7.27%) was also melted at 82-85°C separately. THC (0.2%) was added to the aqueous phase, following which the hot aqueous emulsifier mix, was dropped at once into the lipid melt, under magnetic stirring to obtain a clear microemulsion. The hot microemulsion thus formed, was transferred into an equivalent amount of cold water (2°C) under continuous mechanical stirring (5000 rpm) for 1.5 hour. In the aqueous medium, SLNs were formed by crystallization of the lipid droplets present in the microemulsion.
Incorporation of THC-SLNs into a hydrogel system
For improving the acceptability and patient compliance, prepared THC-SLNs were incorporated into a hydrogel base. Latter is purported to improve the spreadability of the prepared SLNs dispersion on topical application. Carbopol ® 934 (500 mg) was dispersed in 25 mL of water and kept overnight for swelling. Triethanolamine (0.75 g) was added to this mixture with continuous stirring, to effect gelling of Carbopol ® 934. Stirring was continued until a translucent gel was formed. Then, 25 mL of THC-SLNs dispersion was added to the prepared gel and mixed slowly to obtain a homogenous mixture containing 1% w/v of Carbopol ® 934 and 0.2% w/w concentration of THC. Free drug gel comprising of Carbopol ® 934 (1% w/v) was prepared by incorporation of similar THC concentration (0.2% w/w) as contained in THC-SLNs. We wish to highlight here that as THC is not soluble in water, the addition of the drug into the gel base, though produced a nonhomogeneous mixture, in comparison to gel of THC-SLNs, however, it was subjected to homogenization to ensure a uniform distribution of drug in the gel.
Characterization of THC-SLNs and THC-SLNs loaded hydrogel
Particle analysis
The mean diameters of THC-SLNs in the dispersion and blank SLNs were measured with appropriate dilutions with distilled water (1:20) using Delsa TM Nano C (Beckman Coulter, California, USA). It is based on photon correlation spectroscopy, which determines particle size by measuring the rate of fluctuations in laser light intensity scattered by particles as they diffuse through a fluid.
Zeta potential
Zeta potential was determined by using Delsa TM Nano C (Beckman Coulter, California, USA). It measures the electrophoretic movement of the particles under an applied electric field from the doppler shift of scattered light at 25 ᵒC.
Transmission electron microscopy (TEM)
THC-SLNs were observed microscopically using TEM (H-7500, Hitachi Ltd., Japan) for uniformity of size, shape and physical stability characteristics i.e. aggregation or irregularity, at an 
Total drug content (TDC) and entrapment efficiency (EE)
Total drug content (TDC) of THC-SLNs dispersion and THC-SLNs gel was determined by disrupting 1 ml of dispersion and 1 g of gel using mixture of chloroform: methanol (1:1). Latter was centrifuged at 5000 rpm to obtain a clear solution which was filtered (0.2 µm) and analysed spectrophotometrically at λmax of 282 nm using chloroform: methanol (1:1) as blank. Total drug content was calculated from the standard calibration curve.
The entrapment efficiency (EE) of the prepared THC-SLNs dispersion and THC-SLNs hydrogel was determined by using a dialysis membrane having pore size 2.4 nm, molecular weight cut off 12-14 Kda. Membrane was soaked in double-distilled water for 12 hours prior to use. The SLNs dispersion (1 mL) and the hydrogel (1 g) was placed in this pre-soaked dialysis tubing, which was hermetically sealed, and dialyzed against methanol (50 mL) at room temperature for 45 minutes.
The amount of drug released into the receptor/release medium was analysed spectrophotometrically with appropriate dilutions. The SLNs and hydrogel retained in the dialysis bag were disrupted using mixture of chloroform and methanol (1:1) to calculate the amount of drug entrapped within THC-SLNs and its hydrogel 27 . Entrapment efficiency was calculated using the following expression.
Differential scanning calorimetry (DSC) 
X-ray diffraction studies (XRD)
XRD is an advanced and potential technique based on scattered intensity of an X-Ray beam, hitting a sample as a function of incident and scattered angle, polarization and wavelength or energy. The versatility and non-destructive operational procedures of the technique exhibits the crystallographic structure of the raw samples with its finished products 29 .
Powder X-Ray diffraction patterns of THC-SLNs, lipid and pure drug were recorded using XPERT-PRO diffractometer system, using Cu, Kα and Kβ radiations at 45 kV, 40 mA and a temperature of 25 ᵒ C. The samples were analyzed between 2Ɵ angles of over 5-50 ᵒ C.
Determination of pH and rheology
pH of the gel was determined using glass electrode pH meter (Pico+, Lab India). Rheology of the prepared gel was determined using cone and plate type rheometer (Rheolab QC, Anton Paar GmbH, Vienna, Austria) attached with water jacket (C-LTD80/QC) for maintaining constant temperature. Data analysis was carried out using Rheoplus/32 version 3.40. ACC27 spindle geometry was used for measuring the torque as well as viscosity of the sample. Temperature was kept at 30 ᵒ C and shear rate was selected from 0 to 100 s -1 .
Other rheological characteristics i.e. stickiness and force of extrusion of the formulation were evaluated using TTC spreadability rig, fitted on texture analyzer TM (M/s stable micro systems ltd., UK). Approx. 10 g of formulation was placed into the lower cone of the instrument and pressed to remove any air pockets (entrapped air). Excess formulation was scrapped off to leave a flat test area.
Before testing, the upper cone probe was calibrated against lower cone so that the starting point was at same height for each test approx 25 mm above to lower cone. During testing the upper conical probe penetrated into the sample and continued to a depth of 2 mm above the sample holder surfaces i.e. probe moved a distance of 23 mm from its starting point (test speed 3 mm/sec). The force encountered by the upper cone probe to break away from gel when starting to ascend (the point of maximum force) was taken as the measurement of gel strength; the higher the value, better is the strength of gel network. The area of the curve upto this point was taken as measurement of work of shear, reflecting the work of spreadability of the sample. The negative region of the graph, produced on the return of the probe, was a result of the weight of the sample which is lifted primarily on the upper surface of the cone. Latter is evident due to its back movement and hence provides an indication of adhesion or resistance to flow off the disc. The maximum negative region of the curve was taken as work of adhesion of the gel and it represents the force required to extrude from the tube.
Occlusion testing
The occlusive properties of THC-SLNs gel, Tacroz® Forte, blank SLNs gel and blank gel without SLNs (n = 3) were evaluated by in vitro occlusion test 30 . Preweighed beakers (100 mL each) with an internal diameter of 4.9 cm were taken and filled with 50 mL of water and subsequently covered with Whatman filter paper. The formulations were uniformly spread evenly on the surface using a spatula. The beakers were then stored at 32 ± 0.5 °C (to mimic the temperature of the skin surface) for 48 hours. Beakers were weighed at 24, and 48 hours. The percent water loss was quantified and occlusion factor (F) was calculated by the following Equation.
Where F is the occlusion factor, A is the water loss without sample (reference) and B is the water loss with sample.
Stability studies
The stability studies were performed in accordance to the ICH guidelines 31 . THC-SLNs dispersion was kept at 4 ᵒ C ± 3 ᵒ C and 40 ºC ± 2 ºC/75% RH ± 5% RH while THC-SLNs gel was stored at 25 ºC ± 2 ºC/60% RH ± 5% RH and 40 ºC ± 2 ºC/75% RH ± 5% RH respectively and were analysed for total drug content, entrapment efficiency, particle size, and visual changes for 0-2 months.
Further, long term stability studies are planned to be carried out.
In-vitro drug release
In-vitro drug release was performed using dialysis membrane having pore size 2.4 nm, molecular weight cut off 12-14 Kda. The membrane was equilibrated using the release media (2% tween 80 + 10% ethanol + 15% isopropyl alcohol buffer in phosphate buffer pH 7.4) prior to the experiment.
The media (50 mL) was stirred at 50 rpm throughout the experiment, using a magnetic stirrer.
Temperature was maintained at 32 ± 0.5 ⁰C during the whole experiment. THC-SLNs dispersion (0.25 mL), THC-SLNs gel (500 mg), free THC in gel (500 mg), all containing 940 µg of THC were loaded on the dialysis membrane. Samples (3 mL) were withdrawn at 15 minutes, 30 minutes, 1, 2, 4, 6, 8, 10, 12, and 24 hours. Volume of sample withdrawn was replaced with an equal volume of fresh receptor medium. The experiments were carried out for 24 hours. All measurements were done in triplicate at 282 nm. The mechanism of drug release was determined by fitting the release data to several release kinetic models.
Ex-vivo skin permeation studies
Jacketed Franz glass diffusion cells were used for the determination of permeability of THC and its SLNs formulations through pig ear skin. Pig ears were obtained post-sacrifice from a local abattoir before the pig carcass was exposed to the normal high-temperature cleaning procedure.
The subcutaneous fat tissue was removed, and hair present was trimmed carefully as short as possible using scissors without damaging or scratching the surface in order to ensure the integrity of the skin barrier. The barrier integrity of the skin was checked by measuring the transepidermal water loss 32 and criteria for inclusion/exclusion of the skin sample for the studies was set. Excised skin was then carefully mounted on the diffusion cell 33 . These cells consist of the donor and the receptor chambers between which the skin is positioned. Average area of skin in contact with the receptor medium was 3.14 cm 2 and the average receptor chamber volume was 30.0 mL. Circular ear skin pieces equal to or slightly greater than the size of external circumference of donor compartment were cut out (n = 6) and mounted onto the diffusion cell assembly, keeping the stratum corneum side towards the donor compartment and the dermal side in contact with the receptor fluid. The whole system was water jacketed and thermostatically controlled by an external circulating water bath at 32 ± 0.5 o C. The receptor media (2% tween 80 + 10% ethanol + 15% isopropyl alcohol buffer in phosphate buffer pH 7.4) was stirred at 50 rpm throughout the experiment, using a magnetic stirrer. Mounted skin was allowed to equilibrate for 2 hours, after which the receptor media was replaced with fresh media. This was done to remove any water soluble UV absorbing materials present in or released from the skin, which could interfere with the UV spectrophotometric readings of the drug. THC-SLNs dispersion (0.25 mL), THC-SLNs hydrogel (500 mg), THC gel (500 mg), all containing 940 µg of THC along with their respective blank formulations were applied evenly onto the donor side of the skin surface and the donor cell was covered with aluminium foil to prevent losses due to evaporation. At the end of permeation studies (24 hours), the skin surface was wiped with a moist cotton swab several times (6 times) to remove any residual formulation sticking to the skin. The cotton swabs were then put into 10 mL of methanol and vortexed to solubilise and determine the amount of drug left on the skin by measuring the absorbance of this solvent after filtration at 282 nm. The skin was cut into small pieces and kept in methanol (50 mL) for 24 hours for extraction of the drug in the solvent. Latter was then centrifuged and filtered prior to the estimation of drug content by UV spectrophotometer at 282 nm (linearity range 0.5-20 µg/mL). Similar procedure was repeated for blank (skin without any formulation) so as to determine the amount of drug permeated across stratum corneum. 
Acute dermal irritation studies
Acute dermal irritation study was performed in accordance with the OECD guideline 404 31 .
Rabbits (Albino) were divided into two groups (n = 3). One served as control, while the other served as treatment group.
For the preparation of the animals, approximately 24 hours before the test, furs of the animals were removed by closely clipping the dorsal area of the trunk of the animals. Care was taken to avoid abrading the skin, and only the animals with healthy, intact skin were used.
Animals were housed individually and were exposed to normal day light cycle. For feeding, conventional laboratory diet was used with an unrestricted supply of drinking water.
Test procedure
Application of the test substance (THC-SLNs gel)
THC-SLNs gel (0.5 g) was applied to a small area (approximately 6 cm 2 ) of skin. At the end of the exposure period, which was 4 hours, residual test substance was removed. Scores for erythema and oedema were recorded in accordance to the scoring system referred in the guidelines 34 .
In vivo pharmacodynamic activity
Male lacca mice bred in Central Animal House facility of Panjab University, Chandigarh, 
Excision wound mice model
The animals were divided into 5 groups (n = 6) ( Table 1 ). The fur of the animals was removed and skin was sterilised using 70% alcohol. The animals were anaesthetised using ether. Further, a full thickness excision wound of 1 cm diameter was made using sharp scissors. .
Biochemical estimation
Preparation of tissue homogenate
At the end of 14 th day, the mice were sacrificed by ether inhalation. Mice skin was excised and rinsed in ice cold phosphate buffer saline (pH 7.4). The homogenate of the skin 8% (g of skin in volume of phosphate buffer saline) was prepared using tissue homogenizer at 5,000 rpm. It was then, centrifuged at 10,000 rpm at 4 o C for 10 minutes and the clear supernatants were collected and used for the following biochemical estimations of various groups. Protein estimation was performed using biuret test 36 . Lipid peroxidation, reduced glutathione estimation, superoxide dismutase and catalase activity was performed according to the standard referred methods 37, 38 .
Histopathological studies
After 14 th day of the treatment protocol, the animals were sacrificed by ether anaesthesia and treated dorsal area was excised, rinsed with ice cold phosphate buffer saline and fixed in 10% buffered formalin. The skin sections were embedded in paraffin and microtoned. The sections were stained with hematoxylin and eosin and observed under a high power light microscope (40x). The skin sections were evaluated for the skin integrity.
Histopathology of skin samples was carried out at Medicos Centre, Chandigarh-160022, India, under the supervision of a trained pathologist.
Statistical analysis
All the results are expressed as mean±standard deviation (SD). All statistical analysis was performed using graph pad prism 5. Data was analyzed using one-way ANOVA. p-Values < 0.05
were considered as statistically significant.
Results
THC-SLNs were prepared successfully by microemulsification method 26 , which is a spontaneous workable method at lab scale, wherein the crystallisation of hot melt lipid occurs in cold water (2-8 ᵒC), kept under stirring. It is noteworthy to highlight here, that though microemulsions usually contain high surfactant (Tween 80) (30% or above) and co-surfactant (5-10%) concentrations 39 , however, the THC-SLNs hydrogel was optimized suitably to meet the specifications laid by USFDA for inactive ingredients (Tween 80: 7.50% and phosphatidylcholine: 0.50%). Compritol ® 888 ATO was chosen as the lipid component of the SLNs as it is indicated to result in stable dispersions with small particle size 40 .
Characterization of THC-SLNs and gel
Particle size analysis
Mean particle size of THC-SLNs was estimated to be 96.60 nm with a polydispersity index of 0.252, indicating a narrow particle size distribution while the mean particle size of blank SLNs was found to be 102.40 nm with a polydispersity index of 0.299. It is evident that incorporation of THC did not significantly alter the particle size of the nanoparticles. The small particle size obtained with both blank and drug loaded SLNs may be attributed to the presence of satisfactory surfactant and co-surfactant concentration that results in reduction in the surface tension and production of particles with small sizes [41] [42] [43] .
Zeta potential
Zeta potential of THC-SLNs and blank SLNs measured by employing Delsa nano zetasizer at 25
ᵒC was found to be -22 mV and -15 mV respectively. High negative charge indicate towards formation of a stable nano particulate system with lower chances of aggregation post storage for prolonged time period 44 . The negative charge can be associated with the presence of hydroxyl ions on the surface of the lipid nanostructures, and is consistent with the observations in the previous studies 45 .
TEM
TEM showed uniform particles in the of size range of 35-175 nm, thus confirming to the size as observed by photon correlation spectroscopy (PCS) as given in Figure 1 . The particles were ellipsoidal in shape with no aggregation and/or irregularity in the structure of the THC-SLNs.
Total drug content (TDC) and entrapment efficiency (EE)
TDC of THC-SLNs dispersion and THC-SLNs gel was estimated to be 94.51% ± 2.15% and 99.68% ± 0.51% respectively. High values of TDC are indicative of the insignificant losses incurred during the processes of preparation of THC-SLNs by microemulsification technique 46 .
The entrapment efficiency of prepared THC-SLNs and THC-SLNs gel was found to be 69.56% ± 1.35% and 65.95% ± 0.14% (n = 6) respectively. Higher EE indicates the suitability of the method used for the preparation of SLNs.
pH and Rheology
The pH value of THC-SLNs gel was found out to be in range of 6.68 ± 0.21, permitting the safe use of the gel on the skin. The yield value of the THC-SLNs gel was found to be 13.88 Pa which represents its good fluid strength 47 . The value of n (which indicates the shear thinning or shear thickening property of the gel) was less than 1 (n = 0.290), which corroborates the shear thinning nature of the THC-SLNs gel 48 . THC-SLNs gel exhibited consistency index of 77.40 Pa.s, thus affirming good spreadability which is a desirable feature of a topical formulation 49 .
THC-SLNs gel also displayed fairly good gel strength with a low work of shear, and force of extrusion was found to be less than a marketed gel formulation (aceclofenac gel) suggesting the ease of extrudability from the collapsible tube. Though stickiness (sign of adhesiveness) was found to be less than the marketed formulation yet it was enough to hold the formulation at the site of action for a long time. As a comparison with gel was to be made, and in absence of any THC gel drug. Figure 3B also shows distinct peak at 17 ᵒ , however upon incorporation of THC into SLNs no such peak was observed ( Figure 3C ), indicating the amorphous nature of the prepared SLNs.
The amorphous nature is further responsible for the controlled release of the drug from THCSLNs 50 . However, no characteristic peaks in BSLNs indicate the amorphous nature of lipid after transformation into SLNs.
Occlusion testing
Percentage water loss exclusively depends on the ability of the formulation to form an occlusive layer on the skin. There was almost 2 times more percent water loss through the filter paper at the 
Ex-vivo permeation
In order to assess the skin permeation and localization of THC from THC-SLNs, the ex-vivo permeation ability through porcine ear skin was investigated. The comparative amount of drug permeated from all the formulations is given in Figure 4B . The effect of gel as a carrier on accumulation and diffusion of THC through the skin was evaluated using ex-vivo skin permeation studies. During this study, the permeation data of THC-SLNs gel was compared with free THC increasing its penetration as a result of enhanced solubility and small particle size.
Stability studies
The THC-SLNs dispersion and the final formulated THC-SLNs gel were stable at various storage conditions. There was insignificant change (p ≤ 0.05) in particle size, total drug content and entrapment efficiency of THC-SLNs and THC-SLNs gel at 4 ᵒ C ± 3 ᵒ C, 25 ºC ± 2 ºC/60% RH ± 5% RH, 40 ºC ± 2 ºC/75% RH ± 5% RH as given in Tables 3A and B . Though increase in the particle size was observed, however it was below 200 nm, required for enhanced permeation across the stratum corneum 52 . Latter may be assigned to the fact that on cooling SLNs, lipids are not fully crystallized and carbon chains are freezed heterogeneously. With time, carbon chains change their orientation and start forming crystals leading to a change in shape of SLNs which exposes new surfaces that are not coated with surfactant. These uncoated surfaces which are sticky lead to aggregation of SLNs 53, 33 .
Acute dermal irritation studies OECD guideline 404 was followed for acute dermal irritation studies 34 . The formulation was applied for 4 hours and was evaluated after 1, 24, 48 and 72 hours of application. No skin reaction such as erythema and edema was observed in animals for any group.
In-vivo pharmacodynamic study
Excision wound mice model and histopathological study
The in vivo wound healing potential of the THC-SLNs gel was assessed in comparison with the free THC gel using the excision wound mice model 54 . In contrast, immature and disorganized epidermal layers due to delay in full-thickness reepithelialisation, fewer and less obvious areas of blood vessels were noted throughout the scantly formed granulation tissue of the untreated mice Figure 5 (A8). This was further characterized by few fibroblasts, less dense collagen fibres. Whereas, more distinct, thick, densely associated and well organized collagen fibres/bands with normal fibroblasts alignment and persistence of inflammatory cells were found in late granulation tissue of the mice post application of THC-SLNs gel, in comparison to free THC gel and blank SLNs gel.
Biochemical estimation
LPO
In positive control mice, there was a significant increase (p < 0.005) in the MDA levels (2.86 times) as compared to naive mice. In contrast, groups treated with 0.2% w/w of THC-SLNs gel and blank SLNs gel, showed a reduction of MDA levels by 60% and 47.60% respectively.
Furthermore, both these groups produced complete reversal in the elevated MDA levels such that the values were similar (p < 0.05) to those obtained for the naïve control groups ( Figure 6A ). Free THC gel however did not show any significant effect on MDA levels.
Reduced glutathione
There was a significant reduction (p < 0.05) in GSH levels in positive control ( Figure 6B ) as compared to naïve mice (negative control). Treatment with 0.2% w/w THC-SLNs gel increased GSH levels by 2.23 times. However, free THC gel at similar concentrations did not show any significant increase in GSH levels.
SOD assay
The treatment with THC-SLNs gel significantly increased the SOD level, ( Figure 6C ) reduces oxidative stress and ROS generation which indicates its protective role. SOD levels decreased in the positive control group by 9.45 times compared to naive mice. In groups treated with 0.2% w/w THC-SLNs gel, SOD levels were increased by 7.60 times. However, 0.2% w/w free THC gel and blank SLNs gel did not show any significant increase (p < 0.05) in SOD as compared to the THCSLNs gel treated groups.
Catalase assay
Catalase levels decreased in the positive control by 2.21 times compared to naive mice ( Figure   6D ). In groups treated with 0.2% w/w THC-SLNs gel, catalase levels were increased by 2.02 times.
However, 0.2% w/w free THC gel did not show any significant increase (p ≤ 0.05) in catalase levels as compared to the THC-SLNs group.
Discussion
Tetrahydrocurcumin, a stable, hydrogenated product of curcumin has remained as an underexplored molecule to be developed as a topical therapeutic for skin inflammation. Nanotailoring the molecule can improve its aqueous solubility, permeation and retention onto the surface of the skin and can make the molecule bioavailable at the site of application.
Drug permeation across the skin depends on ability of the drug to diffuse out of the vehicle and its penetration through the external cornifying layer (stratum corneum) of the skin 55, 56 . Use of phosphatidylcholine to increase drug transport across rat skin has been reported at much higher concentration (10-15%) than used in THC-SLNs gel (0.5% PC) so as to meet the Inactive Ingredient Guide (IIG) limits specified by Food and Drug Administration (FDA) 57 . Also, the surfactant i.e. Tween 80 is added in accordance to approved IIG limits 58 . The attained particle size, TDC and EE confirmed the suitability of the microemulsification technique for loading white curcumin into lipidic nanoparticles.
TEM examination revealed the existence of particles with ellipsoidal to disc-like shape. DSC and X-Ray diffraction studies confirmed the formation of amorphous THC-SLNs. The ideal occlusivity offered by THC-SLNs gel was assigned to the ability of lipidic nanoparticles to form an adhesive layer upon dermal application and thus occluding the skin surface to avoid the loss of water 59 . As a result, with the enhanced hydration of stratum corneum, the loosening of corneocytes packing occurs, which widens the intercorneocyte gap thus facilitating the drug penetration into deeper skin strata 60 . The results of the excision wound mice model highlighted that THC-SLNs gel, not only possesses anti-oxidant, anti-inflammatory activity but also holds an excellent wound healing potential.
Owing to accelerated epithelialisation, cellular proliferation, formation of granulation tissue, synthesis of collagen tissue, topical application of THC at the wound site produced significant wound healing activity, which may be due to its angiogenic potential. These progressive changes in the epidermal and dermal architecture include: keratinization and full-thickness epidermal regeneration, which covered largely the wound area, intense improvement in the maturation and organization of epidermal layers with no debridement crust covering the epidermal surface, an increase in deposition and organization of extracellular matrix elements.
Wound healing was faster and better in the decreasing order: THC-SLNs gel>free THC gel>positive control. Wound healing rate was significantly higher (p ≤ 0.05) in THC-SLNs gel treated animals than those treated with free THC gel. THC-SLNs gel left no prominent scar at the wound site, pointing towards the enhanced bioactivity of THC post incorporation into SLNs 62 .
Latter was confirmed by the histological investigations, which revealed a complete healing of skin on application of THC-SLNs gel. Similar study reported by Rao et al. (2015) reported the usefulness of glucosylated THC in the process of wound healing 63 . They also confirmed its enhanced percutaneous absorption and potent in vivo wound healing effect. Latter study indicated the role of glycosyl moiety to improve upon the aqueous solubility of THC which subsequently enhances the therapeutic activity of THC. While the bioenhanced activity of THC in our study is assigned to the nanocoutured THC which due to the small particle size exhibits enhanced skin permeation thus highlighting the significance of incorporating the drug into lipidic nanoparticles 33 .
The enhanced antioxidant potential of THC-SLNs gel indicated by a significantly decreased MDA (2.22 times), increased GSH (2.23 times), SOD (7.60 times) and catalase (2.02 times) levels visa-vis free THC gel, are a proof to the biochemical in vivo activity post topical application.
Interestingly, blank SLNs gel also showed some antioxidant properties. This could be due to presence of phosphatidylcholine in the SLN formulation. Use of phosphatidylcholine for a long duration of time is reported to result in decrease in MDA levels 64 . Since, phosphatidylcholine containing SLNs gel, was applied continuously for a time period of 14 days, it could probably be responsible for the observed decreased levels of MDA. Additionally, presentation of phosphatidylcholine (2%) as highly bioavailable SLN formulation would have added to its efficacy 64, 65 . Similar results have been reported in a study by Kadoma and Fujisawa (2007) . They revealed that THC oxidized by peroxy radicals may be more antioxidative than curcumin in the interplay with GSH 66 . In another study, THC was reported to be a better molecule for the inhibition of phospholipase A2, a substrate for proinflammatory mediator than curcumin i.e. prostaglandins;
(which are involved in the process of skin inflammation) 66 . These in vitro and in vivo studies are indicative of the efficacy of THC-SLNs for all the categories of skin ailments.
To the best of our knowledge, this is the first paper highlighting the therapeutic effectiveness of nano-lipidic particles of THC. The in vitro and in vivo studies are indicative of the efficacy of THC-SLNs for all the categories of skin ailments with inflammation. This product is expected to be a one of its kind with its ability to cater to inflammatory condition of the skin of not only the adults but paediatric population as well 67 . Till now, there are no products available for the chronic conditions like dermatitis in the market. The available products belong to the category of steroids, antibiotics and calcineurin inhibitors and the use of these products is associated with serious side effects 68 . Thus, THC-SLNs gel would present safer alternative to the currently available products in the market and provide ease to the patients with chronic skin inflammation. Further studies are necessary to investigate the exact mechanisms related to the findings of the study. Prospective studies to confirm the concentration/presence of the THC in the various layers of the skin, which include the confocal microscopic studies and dermatokinetic modelling are warranted and planned as future protocols. 
